Meningococcal Articles and Studies

  • FDA announced on October 29, 2014 that it has approved the first vaccine to prevent serogroup B Meningococcal disease Additional information can be found on the manufacturer’s press release.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Updated 8/23/18

 

 

This website is supported by an independent educational grant from Merck and an educational grant from Sanofi Pasteur U.S. 
ACOG does not allow companies to influence its programs, publications, or advocacy positions.